학술논문
Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients
Document Type
Article
Author
Ramachandran, Ravishankar; Bhosale, Vivek; Reddy, Himanshu; Atam, Virendra; Faridi, MMA; Fatima, Jalees; Shukla, Vaibhav; Khan, Zaw A; Khan, Hana; Singh, Vikram; Negi, Mahendra Pal Singh; Srivastava, Mukesh; Srivastava, Ajay Kumar; Tripathi, Chandra Bhushan; Ghosh, Nayan; Majumdar, Nilanjana; Tripathi, Raj Kamal; Rath, Srikanta Kumar; Mishra, Prabhat Ranjan; Sharma, Sharad; Kundu, Tapas K
Source
In International Journal of Infectious Diseases February 2022 115:62-69
Subject
Language
ISSN
1201-9712